-
1 Comment
ImpediMed Limited is currently in a long term downtrend where the price is trading 10.3% below its 200 day moving average.
From a valuation standpoint, the stock is 93.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 16.2.
ImpediMed Limited's total revenue rose by 26.2% to $4M since the same quarter in the previous year.
Its net income has increased by 19.3% to $-10M since the same quarter in the previous year.
Finally, its free cash flow grew by 44.5% to $-3M since the same quarter in the previous year.
Based on the above factors, ImpediMed Limited gets an overall score of 4/5.
ISIN | AU000000IPD8 |
---|---|
Exchange | AU |
Sector | Healthcare |
Industry | Medical Devices |
CurrencyCode | AUD |
Beta | 2.57 |
---|---|
PE Ratio | None |
Target Price | 0.1496 |
Market Cap | 79M |
Dividend Yield | None |
ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IPD.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025